Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:2111-2117
Published online before print September 30, 2002, doi: 10.1161/01.CIR.0000033597.45947.0F
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/16/2111    most recent
01.CIR.0000033597.45947.0Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by May, A. E.
Right arrow Articles by Gawaz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by May, A. E.
Right arrow Articles by Gawaz, M.
Related Collections
Right arrow Signal transduction

(Circulation. 2002;106:2111.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Engagement of Glycoprotein IIb/IIIa ({alpha}IIbß3) on Platelets Upregulates CD40L and Triggers CD40L-Dependent Matrix Degradation by Endothelial Cells

Andreas E. May, MD*; Thorsten Kälsch, MD*; Steffen Massberg, MD; Yared Herouy, MD; Roland Schmidt, MD; Meinrad Gawaz, MD

From Medizinische Klinik, Klinikum rechts der Isar and Deutsches Herzzentrum, Technische Universität München, and Department of Dermatology, University Medical School (Y.H.), Freiburg, Germany. Dr Kälsch is now at Medizinische Klinik, Universitätsklinikum Mannheim, Germany.

Correspondence to Meinrad Gawaz, MD, 1. Medizinische Klinik, Klinikum rechts der Isar and Deutsches Herzzentrum, Technische Universität München, Lazarettstraße 36, 80636 München, Germany. E-mail gawaz{at}dhm.mhn.de

Background— CD40L-CD40 interactions induce inflammatory signals in cells of the vascular wall. We evaluated the effects of glycoprotein (GP) IIb/IIIa ({alpha}IIbß3) engagement that occurs during platelet-endothelium interactions on CD40L surface exposure on platelets and initiation of proteolytic activity in human umbilical vein endothelial cells (HUVECs).

Methods and Results— Transient (60-minute) adhesion of thrombin-prestimulated platelets enhanced HUVEC expression of urokinase-type plasminogen activator receptor and membrane type-1 matrix metalloproteinase (MT1-MMP) (reverse transcriptase–polymerase chain reaction, flow cytometry) and secretion of urokinase-type plasminogen activator, tissue-type plasminogen activator, and MMP-1 (ELISA) and induced proteolytic activity via MMP-2 and MMP-9 (gelatin zymography). These effects were abrogated by hindrance of physical platelet-endothelial contacts using transwell systems or inhibited by GRGDSP, mAbs anti–GP IIb/IIIa (7E3), anti-{alpha}vß3 (LM609), or anti-CD40L (TRAP1). In addition, MMP-2 and MMP-9 were inhibited by specific GP IIb/IIIa antagonists tirofiban, lamifiban, or integrelin. On endothelial cells, induction of proteolytic activity by activated platelets was mimicked by CD40 engagement using soluble CD40L but not affected by antibody clustering of {alpha}vß3. On platelets, CD40L and CD62P exposure was enhanced on adhesion to HUVECs or immobilized fibrinogen and was abrogated by GRGDSP or LM609. In suspension, cross-linking of GP IIb/IIIa by fibrinogen plus secondary mAb upregulated CD40L surface exposure. Consistently, bivalent mAb 7E3 upregulated CD40L, whereas ligation of GP IIb/IIIa by soluble fibrinogen alone or monovalent Fab-fragment c7E3 had no effect.

Conclusions— Platelet adhesion via GP IIb/IIIa upregulates CD40L and CD62P surface exposure. Proteolytic activity of HUVEC is induced by the concerted action of ß3-integrin–mediated platelet adhesion and subsequent CD40L-induced signals in HUVECs. Effective anti–GP IIb/IIIa or anti-CD40L strategies might, therefore, contribute to plaque stabilization.


Key Words: platelets • arteriosclerosis • endothelium • metalloproteinases




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. M. van Gils, J. J. Zwaginga, and P. L. Hordijk
Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases
J. Leukoc. Biol., February 1, 2009; 85(2): 195 - 204.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. F. Langer, R. Haubner, B. J. Pichler, and M. Gawaz
Radionuclide imaging a molecular key to the atherosclerotic plaque.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Siegel-Axel, K. Daub, P. Seizer, S. Lindemann, and M. Gawaz
Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis
Cardiovasc Res, April 1, 2008; 78(1): 8 - 17.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. Charrier-Hisamuddin, C. L. Laboisse, and D. Merlin
ADAM-15: a metalloprotease that mediates inflammation
FASEB J, March 1, 2008; 22(3): 641 - 653.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. E. May, P. Seizer, and M. Gawaz
Platelets: Inflammatory Firebugs of Vascular Walls
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): s5 - s10.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. F. Brass, L. Zhu, and T. J. Stalker
Novel Therapeutic Targets at the Platelet Vascular Interface
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): s43 - s50.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Schmidt, A. Bultmann, S. Fischel, A. Gillitzer, P. Cullen, A. Walch, P. Jost, M. Ungerer, N. D. Tolley, S. Lindemann, et al.
Extracellular Matrix Metalloproteinase Inducer (CD147) Is a Novel Receptor on Platelets, Activates Platelets, and Augments Nuclear Factor {kappa}B-Dependent Inflammation in Monocytes
Circ. Res., February 15, 2008; 102(3): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Stellos, H. Langer, K. Daub, T. Schoenberger, A. Gauss, T. Geisler, B. Bigalke, I. Mueller, M. Schumm, I. Schaefer, et al.
Platelet-Derived Stromal Cell-Derived Factor-1 Regulates Adhesion and Promotes Differentiation of Human CD34+ Cells to Endothelial Progenitor Cells
Circulation, January 15, 2008; 117(2): 206 - 215.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Massberg, I. Konrad, K. Schurzinger, M. Lorenz, S. Schneider, D. Zohlnhoefer, K. Hoppe, M. Schiemann, E. Kennerknecht, S. Sauer, et al.
Platelets secrete stromal cell-derived factor 1{alpha} and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo
J. Exp. Med., May 15, 2006; 203(5): 1221 - 1233.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Schmidt, A. Bultmann, M. Ungerer, N. Joghetaei, O. Bulbul, S. Thieme, T. Chavakis, B. P. Toole, M. Gawaz, A. Schomig, et al.
Extracellular Matrix Metalloproteinase Inducer Regulates Matrix Metalloproteinase Activity in Cardiovascular Cells: Implications in Acute Myocardial Infarction
Circulation, February 14, 2006; 113(6): 834 - 841.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Langer, A. E. May, K. Daub, U. Heinzmann, P. Lang, M. Schumm, D. Vestweber, S. Massberg, T. Schonberger, I. Pfisterer, et al.
Adherent Platelets Recruit and Induce Differentiation of Murine Embryonic Endothelial Progenitor Cells to Mature Endothelial Cells In Vitro
Circ. Res., February 3, 2006; 98(2): e2 - e10.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Santilli, G. Davi, A. Consoli, F. Cipollone, A. Mezzetti, A. Falco, T. Taraborelli, E. Devangelio, G. Ciabattoni, S. Basili, et al.
Thromboxane-Dependent CD40 Ligand Release in Type 2 Diabetes Mellitus
J. Am. Coll. Cardiol., January 17, 2006; 47(2): 391 - 397.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Massberg, K. Schurzinger, M. Lorenz, I. Konrad, C. Schulz, N. Plesnila, E. Kennerknecht, M. Rudelius, S. Sauer, S. Braun, et al.
Platelet Adhesion Via Glycoprotein IIb Integrin Is Critical for Atheroprogression and Focal Cerebral Ischemia: An In Vivo Study in Mice Lacking Glycoprotein IIb
Circulation, August 23, 2005; 112(8): 1180 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Ueland, P. Aukrust, A. Yndestad, K. Otterdal, S. S. Froland, K. Dickstein, J. Kjekshus, L. Gullestad, and J. K. Damas
Soluble CD40 ligand in acute and chronic heart failure
Eur. Heart J., June 1, 2005; 26(11): 1101 - 1107.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Fateh-Moghadam, Z. Li, S. Ersel, T. Reuter, P. Htun, U. Plockinger, W. Bocksch, R. Dietz, and M. Gawaz
Platelet Degranulation Is Associated With Progression of Intima-Media Thickness of the Common Carotid Artery in Patients With Diabetes Mellitus Type 2
Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1299 - 1303.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ishikawa, T. Vowinkel, K. Y. Stokes, T. V. Arumugam, G. Yilmaz, A. Nanda, and D. N. Granger
CD40/CD40 Ligand Signaling in Mouse Cerebral Microvasculature After Focal Ischemia/Reperfusion
Circulation, April 5, 2005; 111(13): 1690 - 1696.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Ungerer, M. Peluso, A. Gillitzer, S. Massberg, U. Heinzmann, C. Schulz, G. Munch, and M. Gawaz
Generation of Functional Culture-Derived Platelets From CD34+ Progenitor Cells to Study Transgenes in the Platelet Environment
Circ. Res., September 3, 2004; 95(5): e36 - e44.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Cabeza, Z. Li, C. Schulz, E. Kremmer, S. Massberg, A. Bultmann, and M. Gawaz
Surface Expression of Collagen Receptor Fc Receptor-{gamma}/Glycoprotein VI Is Enhanced on Platelets in Type 2 Diabetes and Mediates Release of CD40 Ligand and Activation of Endothelial Cells
Diabetes, August 1, 2004; 53(8): 2117 - 2121.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kinlay, G. G. Schwartz, A. G. Olsson, N. Rifai, W. J. Sasiela, M. Szarek, P. Ganz, P. Libby, and for the Myocardial Ischemia Reduction with Aggress
Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study
Circulation, July 27, 2004; 110(4): 386 - 391.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Aukrust, J. K. Damas, and N. O. Solum
Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?
J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2326 - 2328.
[Full Text] [PDF]


Home page
StrokeHome page
J. Raymond, F. Guilbert, A. Metcalfe, G. Gevry, I. Salazkin, and O. Robledo
Role of the Endothelial Lining in Recurrences After Coil Embolization: Prevention of Recanalization by Endothelial Denudation
Stroke, June 1, 2004; 35(6): 1471 - 1475.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Schafer, F. Wiesmann, S. Neubauer, M. Eigenthaler, J. Bauersachs, and K. M. Channon
Rapid Regulation of Platelet Activation In Vivo by Nitric Oxide
Circulation, April 20, 2004; 109(15): 1819 - 1822.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Gawaz
Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium
Cardiovasc Res, February 15, 2004; 61(3): 498 - 511.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Schafer, C. Schulz, M. Eigenthaler, D. Fraccarollo, A. Kobsar, M. Gawaz, G. Ertl, U. Walter, and J. Bauersachs
Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion
Blood, January 15, 2004; 103(2): 407 - 412.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
T. E. Warkentin, W. C. Aird, and J. H. Rand
Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome
Hematology, January 1, 2003; 2003(1): 497 - 519.
[Abstract] [Full Text] [PDF]